A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Alicaforsen (Primary)
  • Indications Pouchitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Atlantic Pharmaceuticals
  • Most Recent Events

    • 08 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 15 Sep 2017.
    • 08 Mar 2017 Planned end date changed from 1 Apr 2017 to 18 Jan 2018.
    • 11 Feb 2016 According to an Atlantic Healthcare media release, the results of this study are expected in H2 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top